Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

Note 9 - Share Capital - Warrant Exercises (Details)

v3.8.0.1
Note 9 - Share Capital - Warrant Exercises (Details)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2015
USD ($)
shares
Statement Line Items [Line Items]  
Number of warrants exercised (in shares) | shares 81
Exercise of warrants (note 9(c)) | $ $ 279
August 2011 Warrants [Member]  
Statement Line Items [Line Items]  
Number of warrants exercised (in shares) | shares 16 [1]
Exercise of warrants (note 9(c)) | $ $ 68 [1]
June 2013 Private Placement Warrants [Member]  
Statement Line Items [Line Items]  
Number of warrants exercised (in shares) | shares 47 [2]
Exercise of warrants (note 9(c)) | $ $ 115 [2]
December 2013 Broker Warrants [Member]  
Statement Line Items [Line Items]  
Number of warrants exercised (in shares) | shares 18 [3]
Exercise of warrants (note 9(c)) | $ $ 96 [3]
[1] August 2011 warrants were exercisable into common shares of Aptose at a price per share of $5.40 and expired in August 2016.
[2] June 2013 private placement warrants were exercisable into common shares of Aptose at a price per share of $3.00 and expired in June 2015.
[3] December 2013 broker warrants were exercisable into common shares of Aptose at a price per share of $6.60 and expired in December 2015.